Johnson & Johnson (NYSE: JNJ) open the trading on Thursday, with a bit cautious approach as it glided -0.04% to $185.98, before settling in for the price of $186.05 at the close. Taking a more long-term approach, JNJ posted a 52-week range of $140.68-$186.56.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 0.55%. Meanwhile, its Annual Earning per share during the time was 0.55%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.78%. This publicly-traded company’s shares outstanding now amounts to $2.41 billion, simultaneously with a float of $2.41 billion. The organization now has a market capitalization sitting at $447.90 billion. At the time of writing, stock’s 50-day Moving Average stood at $175.65, while the 200-day Moving Average is $159.97.
Johnson & Johnson (JNJ) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – General industry. Johnson & Johnson’s current insider ownership accounts for 0.12%, in contrast to 73.87% institutional ownership. According to the most recent insider trade that took place on Sep 04 ’25, this organization’s EVP, WWC. Innovative Medicine sold 56,471 shares at the rate of 177.81, making the entire transaction reach 10,040,883 in total value, affecting insider ownership by 178,013.
Johnson & Johnson (JNJ) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.57 per share during the current fiscal year.
Johnson & Johnson’s EPS increase for this current 12-month fiscal period is 8.78% and is forecasted to reach 11.38 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 6.88% through the next 5 years, which can be compared against the 0.55% growth it accomplished over the previous five years trading on the market.
Johnson & Johnson (NYSE: JNJ) Trading Performance Indicators
Let’s observe the current performance indicators for Johnson & Johnson (JNJ). It’s Quick Ratio in the last reported quarter now stands at 0.76. Alongside those numbers, its PE Ratio stands at $19.89, and its Beta score is 0.37. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 4.94. Similarly, its price to free cash flow for trailing twelve months is now 24.15.
In the same vein, JNJ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 9.35, a figure that is expected to reach 2.75 in the next quarter, and analysts are predicting that it will be 11.38 at the market close of one year from today.
Technical Analysis of Johnson & Johnson (JNJ)
[Johnson & Johnson, JNJ] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 95.58% While, its Average True Range was 76.92.
Raw Stochastic average of Johnson & Johnson (JNJ) in the period of the previous 100 days is set at 98.49%, which indicates a major rise in contrast to 95.40% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 2.57 that was higher than 2.33 volatility it exhibited in the past 100-days period.
